FONTES DE INFORMAÇÃO
Acervos Bibliográficos
BVS DIP
Inovação e propriedade intelectual
Memórias do IOC
Obras Raras
Teses Fiocruz
Videoteca
E mais...
SERVIÇOS
Catalogação na fonte
Comutação
Conservação e preservação
Ebooks
Empréstimo pessoal
Empréstimo entre bibliotecas
Formulário de inscrição
Mesa de Quarta-feira
Novas Aquisições
Reserva
Solicitação de cópias
Visitas orientadas
Ficha Catalográfica
PRODUTOS
Boletim
Exposição
Série Biografias
Série Doenças
Série Fontes de Referências
UTILIDADES
Conveniências no local
Normalização
Como chegar
Fale Conosco
Mapa do sítio
Nossa equipe
Perguntas freqüentes
CANDIDÍASE
(1)
ALVES, I. A. et al. Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole. Mycopathologia, The Hague, v. 174, n. 3, p. 215-221, Sept. 2012.
(2)
CARVALHO, P. G. C. de. et al. Concanavalin-A induces IL-17 production during the course of Candida albicans infection. FEMS immunologyl and medical microbiology, Amsterdam, v. 64, n. 2, p. 273-279, Feb. 2012.
(3)
COLOMBO, T. E. et al. Identification of fungal diseases at necropsy.Pathology research and practice, Munchen, v. 208, n. 9, p. 549-552, Sept. 2012.
(4)
GONDAK, R. O. et al. Depletion of Langerhans cells in the tongue from patients with advanced-stage acquired immune deficiency syndrome: relation to opportunistic infections. Histopathology, Oxford, v. 60, n. 3, p. 497-503, Feb. 2012.
(5)
MORAES, A. P. de et al. Effect of triazine derivative added to denture materials on a microcosm biofilm model. Journal of biomedical materials research, part B, applied biomaterials, Hoboken, v. 100, n. 5, p. 1328-1333, July 2012.
(6)
PFALLER, M. A. et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. Journal of clinical microbiology, Washington, v. 50, n. 6, p. 2040-2046, June 2012.
(7)
ROSSI, D. C. et al. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis. BMC microbiology, London, v. 12, n. 28, 2012.
(8)
SARDI, J. C. O. et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of medical microbiology, Edinburgh, v. 62, n. 1, p. 10-24, Jan. 2013.
(9)
STORTI, L. R. Et al. Candida spp. isolated from inpatients, the environment, and health practitioners in the Pediatric Unit at the Universitary Hospital of the Jundiaí Medical College, State of São Paulo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, Brasília, v. 45, n. 2, p. 225-231., mar./abr. 2012.
(10)
VAUTIER, S. et al. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infection and immunity, Washington, v. 80, n. 12, p. 4216-4222, Dec. 2012.